把手 发表于 2025-3-26 23:22:50
Jürgen Faißt number of protocols.With both new and well established techAntibodies are indispensable tools for research, diagnosis, and therapy. Recombinant approaches allow the modification and improvement of nearly all antibody properties, such as affinity, valency, specificity, stability, serum half-life, efcalamity 发表于 2025-3-27 03:52:30
http://reply.papertrans.cn/43/4262/426170/426170_32.png远足 发表于 2025-3-27 05:16:33
http://reply.papertrans.cn/43/4262/426170/426170_33.pngAtaxia 发表于 2025-3-27 11:30:05
http://reply.papertrans.cn/43/4262/426170/426170_34.pngOffensive 发表于 2025-3-27 16:45:20
Jürgen Faißt number of protocols.With both new and well established techAntibodies are indispensable tools for research, diagnosis, and therapy. Recombinant approaches allow the modification and improvement of nearly all antibody properties, such as affinity, valency, specificity, stability, serum half-life, ef消息灵通 发表于 2025-3-27 19:24:33
number of protocols.With both new and well established techAntibodies are indispensable tools for research, diagnosis, and therapy. Recombinant approaches allow the modification and improvement of nearly all antibody properties, such as affinity, valency, specificity, stability, serum half-life, efAcumen 发表于 2025-3-27 23:06:20
http://reply.papertrans.cn/43/4262/426170/426170_37.png假设 发表于 2025-3-28 03:33:58
http://reply.papertrans.cn/43/4262/426170/426170_38.png护身符 发表于 2025-3-28 08:30:15
http://reply.papertrans.cn/43/4262/426170/426170_39.png弯腰 发表于 2025-3-28 12:20:16
http://reply.papertrans.cn/43/4262/426170/426170_40.png